Currently Available Non-Balloon Devices

by Hang Lak Lee
Published 2018-09-01

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy

by Harold Ray Garner, Mark Burkart, Cristi Lara Galindo, Amina Torkia Tassa, Mounir Errami
Published 2010-02-01

Chronological Review and Rational and Future Prospects of Cannabis-Based Drug Development

by Dvora Namdar, Omer Anis, Patrick Poulin, Hinanit Koltai
Published 2020-10-01

Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines

by Fernando Durães, Emília Sousa
Published 2019-04-01

Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice

by Chunfeng Li, Xingliang Zhu, Xue Ji, Natalie Quanquin, Yong-Qiang Deng, Min Tian, Roghiyh Aliyari, Xiangyang Zuo, Ling Yuan, Shabbir Khan Afridi, Xiao-Feng Li, Jae U. Jung, Karin Nielsen-Saines, Frank Xiao-Feng Qin, Cheng-Feng Qin, Zhiheng Xu, Genhong Cheng
Published 2017-10-01

Exploring targeted therapy of osteosarcoma using proteomics data

by Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D
Published 2017-02-01

Deferiprone (DFP) Targets Cancer Stem cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production

by Marco Fiorillo, Fanni Tóth, Matteo Brindisi, Federica Sotgia, Michael P. Lisanti
Published 2020-06-01

The effect of an antibiotic stewardship program on tigecycline use in a Tertiary Care Hospital, an intervention study

by Rima Moghnieh, Dania Abdallah, Lyn Awad, Marwa Jadayel, Nicholas Haddad, Hani Tamim, Aline Zaiter, Diana-Caroline Awwad, Loubna Sinno, Salam El-Hassan, Rawad Lakkis, Rabab Khalil, Tamima Jisr
Published 2020-08-01

Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification

by Yan Wang, Chu-Ying Xiao, Huang-Quan Lin, Jian-Shu Hu, Tsz-Ming Ip, David Chi-Cheong Wan
Published 2020-07-01

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors

by Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi
Published 2020-10-01

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

by Dr. Chenshu Xu, Haoman Zou, Xi Yu, Yazhou Xie, Jiaxin Cai, Qi Shang, Na Ouyang, Dr. Yinan Wang, Dr. Pan Xu, Dr. Zhendan He, Dr. Haiqiang Wu
Published 2021-09-01

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients

by Ye Wang, Zhuang Tong, Wenhua Zhang, Weizhen Zhang, Anton Buzdin, Anton Buzdin, Anton Buzdin, Xiaofeng Mu, Xiaofeng Mu, Qing Yan, Xiaowen Zhao, Hui-Hua Chang, Mark Duhon, Xin Zhou, Gexin Zhao, Hong Chen, Xinmin Li
Published 2021-06-01

Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort

by Somayye Taghvaei, Farzaneh Sabouni, Zarrin Minuchehr
Published 2021-07-01

Targeting Energy Expenditure—Drugs for Obesity Treatment

by Carlos M. Jimenez-Munoz, Marta López, Fernando Albericio, Kamil Makowski
Published 2021-05-01

Screening of an FDA-Approved Library for Novel Drugs against <i>Y. pestis</i>

by David Gur, Theodor Chitlaru, Emanuelle Mamroud, Ayelet Zauberman
Published 2021-01-01

Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors

by Prateek Kumar, Deepak Kumar, Rajanish Giri
Published 2019-08-01

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study

by Gema Lizbeth Ramírez-Salinas, Marlet Martínez-Archundia, José Correa-Basurto, Jazmín García-Machorro
Published 2020-11-01

Development and Challenges of Antimicrobial Peptides for Therapeutic Applications

by Charles H. Chen, Timothy K. Lu
Published 2020-01-01

Identification of FDA-Approved Drugs with Activity against Stationary Phase <em>Bartonella henselae</em>

by Tingting Li, Jie Feng, Shuzhen Xiao, Wanliang Shi, David Sullivan, Ying Zhang
Published 2019-04-01

Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin

by Marta Mariniello, Raffaella Petruzzelli, Luca G. Wanderlingh, Raffaele La Montagna, Annamaria Carissimo, Francesca Pane, Angela Amoresano, Ekaterina Y. Ilyechova, Michael M. Galagudza, Federico Catalano, Roberta Crispino, Ludmila V. Puchkova, Diego L. Medina, Roman S. Polishchuk
Published 2020-03-01